Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A multicenter study of prevalence and risk factors for aberrant crypt foci.

Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D, Charabaty A, Chia D, Umar A, Viner J, Hawk E, Pinsky PF.

Clin Gastroenterol Hepatol. 2009 May;7(5):568-74.

PMID:
19418605
2.

Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.

Anderson JC, Swede H, Rustagi T, Protiva P, Pleau D, Brenner BM, Rajan TV, Heinen CD, Levine JB, Rosenberg DW.

Cancer Causes Control. 2012 Feb;23(2):355-61. doi: 10.1007/s10552-011-9884-7. Epub 2011 Dec 21.

PMID:
22187142
3.

Increased frequency of serrated aberrant crypt foci among smokers.

Anderson JC, Pleau DC, Rajan TV, Protiva P, Swede H, Brenner B, Heinen CD, Lambrecht RW, Rosenberg DW.

Am J Gastroenterol. 2010 Jul;105(7):1648-54. doi: 10.1038/ajg.2010.109. Epub 2010 Mar 16.

PMID:
20234347
4.

Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.

Sakai E, Takahashi H, Kato S, Uchiyama T, Hosono K, Endo H, Maeda S, Yoneda M, Taguri M, Nakajima A.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1918-24. doi: 10.1158/1055-9965.EPI-11-0104. Epub 2011 Jul 12.

5.

Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.

Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS.

Am J Gastroenterol. 2005 Jun;100(6):1283-9.

PMID:
15929758
6.

Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.

Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, Lampe PD, Bronner MP, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):605-8.

7.

Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.

Uchiyama T, Takahashi H, Endo H, Kato S, Sakai E, Hosono K, Yoneda M, Inamori M, Hippo Y, Nakagama H, Nakajima A.

Dig Endosc. 2012 Sep;24(5):353-7. doi: 10.1111/j.1443-1661.2012.01289.x. Epub 2012 Apr 2.

PMID:
22925289
8.

The natural history of aberrant crypt foci.

Schoen RE, Mutch M, Rall C, Dry SM, Seligson D, Umar A, Pinsky P.

Gastrointest Endosc. 2008 Jun;67(7):1097-102. doi: 10.1016/j.gie.2007.08.048. Epub 2008 Feb 21.

PMID:
18178205
9.

Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy.

Chung SJ, Kim YS, Yang SY, Song JH, Park MJ, Kim JS, Jung HC, Song IS.

J Gastroenterol Hepatol. 2010 Mar;25(3):519-25. doi: 10.1111/j.1440-1746.2009.06147.x.

PMID:
20370730
10.

Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.

Seike K, Koda K, Oda K, Kosugi C, Shimizu K, Nishimura M, Shioiri M, Takano S, Ishikura H, Miyazaki M.

Am J Gastroenterol. 2006 Jun;101(6):1362-9.

PMID:
16771962
11.

Aberrant crypt foci in the adenoma prevention with celecoxib trial.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM.

Cancer Prev Res (Phila). 2008 Jun;1(1):21-31. doi: 10.1158/1940-6207.CAPR-07-0011. Epub 2008 Apr 14.

12.

Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.

Freire P, Figueiredo P, Cardoso R, Manuel Donato M, Ferreira M, Mendes S, Silva MR, Cipriano MA, Ferreira AM, Vasconcelos H, Portela F, Sofia C.

Scand J Gastroenterol. 2014 Oct;49(10):1219-29. doi: 10.3109/00365521.2014.951390. Epub 2014 Aug 26.

PMID:
25157637
13.

Aberrant crypt foci of the colon as precursors of adenoma and cancer.

Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y.

N Engl J Med. 1998 Oct 29;339(18):1277-84.

14.

One year recurrence of aberrant crypt foci.

Pinsky PF, Fleshman J, Mutch M, Rall C, Charabaty A, Seligson D, Dry S, Umar A, Schoen RE.

Cancer Prev Res (Phila). 2010 Jul;3(7):839-43. doi: 10.1158/1940-6207.CAPR-09-0257. Epub 2010 Jun 22.

15.

Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population.

Moxon D, Raza M, Kenney R, Ewing R, Arozullah A, Mason JB, Carroll RE.

Clin Gastroenterol Hepatol. 2005 Mar;3(3):271-8.

PMID:
15765447
16.

Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.

Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, Suzuki K, Iida H, Sakamoto Y, Yoneda K, Koide T, Tokoro C, Abe Y, Inamori M, Nakagama H, Nakajima A.

Cancer Prev Res (Phila). 2010 Sep;3(9):1077-83. doi: 10.1158/1940-6207.CAPR-10-0186. Epub 2010 Sep 1.

17.

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

Gupta AK, Schoen RE.

Curr Opin Gastroenterol. 2009 Jan;25(1):59-65. doi: 10.1097/MOG.0b013e32831db286. Review.

PMID:
19114775
18.

Aberrant crypt focus size predicts distal polyp histopathology.

Kim J, Ng J, Arozulllah A, Ewing R, Llor X, Carroll RE, Benya RV.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1155-62. doi: 10.1158/1055-9965.EPI-07-2731.

19.

Sex differences in associations between psychosocial factors and aberrant crypt foci among patients at risk for colon cancer.

O'Leary KE, Cruess DG, Pleau D, Swede H, Anderson J, Rosenberg D.

Gend Med. 2011 Jun;8(3):165-71. doi: 10.1016/j.genm.2011.03.009. Epub 2011 May 4.

PMID:
21543265
20.

Is metabolic syndrome a risk factor for colorectal adenoma?

Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1543-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk